Citizens Reiterates Market Outperform Rating on Biomea Fusion
Citizens reiterated its Market Outperform rating and $7 price target on Biomea Fusion. The target implies 455.6% upside from the Oct. 13 close of $1.26.
Citizens reiterated its Market Outperform rating and $7 price target on Biomea Fusion. The target implies 455.6% upside from the Oct. 13 close of $1.26.